Alnylam Pharmaceuticals logo
Alnylam Pharmaceuticals ALNY
$ 249.79 0.4%

Quarterly report 2024-Q3
added 10-31-2024

report update icon

Alnylam Pharmaceuticals Cash Conversion Cycle 2011-2024 | ALNY

Annual Cash Conversion Cycle Alnylam Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
57 75.6 80.5 91 166 -7.13 K - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
166 -7.13 K -1.11 K

Quarterly Cash Conversion Cycle Alnylam Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
68.9 61.1 101 - 69.2 130 176 - 97.4 36.4 91.8 - 159 101 116 18.7 126 146 124 19 133 167 -370 24.4 -23.5 K 17.2 82.6 58.5 80.2 141 138 - - - - - - - - - - - - - - - - - -5.88 -8.33 -80.7 - -287 -132 -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
176 -23.5 K -663